2024-04-012025-03-312025-03-31false13542265NORTH ISLINGTON INTEGRATED CARE LIMITED2025-11-18falseiso4217:GBPxbrli:pure135422652024-03-31135422652025-03-31135422652024-04-012025-03-31135422652023-03-31135422652024-03-31135422652023-04-012024-03-3113542265bus:SmallEntities2024-04-012025-03-3113542265bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3113542265bus:FullAccounts2024-04-012025-03-3113542265bus:PrivateLimitedCompanyLtd2024-04-012025-03-3113542265core:WithinOneYear2025-03-3113542265core:AfterOneYear2025-03-3113542265core:WithinOneYear2024-03-3113542265core:AfterOneYear2024-03-3113542265core:ShareCapital2025-03-3113542265core:SharePremium2025-03-3113542265core:RevaluationReserve2025-03-3113542265core:OtherReservesSubtotal2025-03-3113542265core:RetainedEarningsAccumulatedLosses2025-03-3113542265core:ShareCapital2024-03-3113542265core:SharePremium2024-03-3113542265core:RevaluationReserve2024-03-3113542265core:OtherReservesSubtotal2024-03-3113542265core:RetainedEarningsAccumulatedLosses2024-03-3113542265core:LandBuildings2025-03-3113542265core:PlantMachinery2025-03-3113542265core:Vehicles2025-03-3113542265core:FurnitureFittings2025-03-3113542265core:OfficeEquipment2025-03-3113542265core:NetGoodwill2025-03-3113542265core:IntangibleAssetsOtherThanGoodwill2025-03-3113542265core:ListedExchangeTraded2025-03-3113542265core:UnlistedNon-exchangeTraded2025-03-3113542265core:LandBuildings2024-03-3113542265core:PlantMachinery2024-03-3113542265core:Vehicles2024-03-3113542265core:FurnitureFittings2024-03-3113542265core:OfficeEquipment2024-03-3113542265core:NetGoodwill2024-03-3113542265core:IntangibleAssetsOtherThanGoodwill2024-03-3113542265core:ListedExchangeTraded2024-03-3113542265core:UnlistedNon-exchangeTraded2024-03-3113542265core:LandBuildings2024-04-012025-03-3113542265core:PlantMachinery2024-04-012025-03-3113542265core:Vehicles2024-04-012025-03-3113542265core:FurnitureFittings2024-04-012025-03-3113542265core:OfficeEquipment2024-04-012025-03-3113542265core:NetGoodwill2024-04-012025-03-3113542265core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113542265core:ListedExchangeTraded2024-04-012025-03-3113542265core:UnlistedNon-exchangeTraded2024-04-012025-03-3113542265core:MoreThanFiveYears2024-04-012025-03-3113542265core:Non-currentFinancialInstruments2025-03-3113542265core:Non-currentFinancialInstruments2024-03-3113542265dpl:CostSales2024-04-012025-03-3113542265dpl:DistributionCosts2024-04-012025-03-3113542265core:LandBuildings2024-04-012025-03-3113542265core:PlantMachinery2024-04-012025-03-3113542265core:Vehicles2024-04-012025-03-3113542265core:FurnitureFittings2024-04-012025-03-3113542265core:OfficeEquipment2024-04-012025-03-3113542265dpl:AdministrativeExpenses2024-04-012025-03-3113542265core:NetGoodwill2024-04-012025-03-3113542265core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113542265dpl:GroupUndertakings2024-04-012025-03-3113542265dpl:ParticipatingInterests2024-04-012025-03-3113542265dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3113542265core:ListedExchangeTraded2024-04-012025-03-3113542265dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3113542265core:UnlistedNon-exchangeTraded2024-04-012025-03-3113542265dpl:CostSales2023-04-012024-03-3113542265dpl:DistributionCosts2023-04-012024-03-3113542265core:LandBuildings2023-04-012024-03-3113542265core:PlantMachinery2023-04-012024-03-3113542265core:Vehicles2023-04-012024-03-3113542265core:FurnitureFittings2023-04-012024-03-3113542265core:OfficeEquipment2023-04-012024-03-3113542265dpl:AdministrativeExpenses2023-04-012024-03-3113542265core:NetGoodwill2023-04-012024-03-3113542265core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113542265dpl:GroupUndertakings2023-04-012024-03-3113542265dpl:ParticipatingInterests2023-04-012024-03-3113542265dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3113542265core:ListedExchangeTraded2023-04-012024-03-3113542265dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3113542265core:UnlistedNon-exchangeTraded2023-04-012024-03-3113542265core:NetGoodwill2025-03-3113542265core:IntangibleAssetsOtherThanGoodwill2025-03-3113542265core:LandBuildings2025-03-3113542265core:PlantMachinery2025-03-3113542265core:Vehicles2025-03-3113542265core:FurnitureFittings2025-03-3113542265core:OfficeEquipment2025-03-3113542265core:AfterOneYear2025-03-3113542265core:WithinOneYear2025-03-3113542265core:ListedExchangeTraded2025-03-3113542265core:UnlistedNon-exchangeTraded2025-03-3113542265core:ShareCapital2025-03-3113542265core:SharePremium2025-03-3113542265core:RevaluationReserve2025-03-3113542265core:OtherReservesSubtotal2025-03-3113542265core:RetainedEarningsAccumulatedLosses2025-03-3113542265core:NetGoodwill2024-03-3113542265core:IntangibleAssetsOtherThanGoodwill2024-03-3113542265core:LandBuildings2024-03-3113542265core:PlantMachinery2024-03-3113542265core:Vehicles2024-03-3113542265core:FurnitureFittings2024-03-3113542265core:OfficeEquipment2024-03-3113542265core:AfterOneYear2024-03-3113542265core:WithinOneYear2024-03-3113542265core:ListedExchangeTraded2024-03-3113542265core:UnlistedNon-exchangeTraded2024-03-3113542265core:ShareCapital2024-03-3113542265core:SharePremium2024-03-3113542265core:RevaluationReserve2024-03-3113542265core:OtherReservesSubtotal2024-03-3113542265core:RetainedEarningsAccumulatedLosses2024-03-3113542265core:NetGoodwill2023-03-3113542265core:IntangibleAssetsOtherThanGoodwill2023-03-3113542265core:LandBuildings2023-03-3113542265core:PlantMachinery2023-03-3113542265core:Vehicles2023-03-3113542265core:FurnitureFittings2023-03-3113542265core:OfficeEquipment2023-03-3113542265core:AfterOneYear2023-03-3113542265core:WithinOneYear2023-03-3113542265core:ListedExchangeTraded2023-03-3113542265core:UnlistedNon-exchangeTraded2023-03-3113542265core:ShareCapital2023-03-3113542265core:SharePremium2023-03-3113542265core:RevaluationReserve2023-03-3113542265core:OtherReservesSubtotal2023-03-3113542265core:RetainedEarningsAccumulatedLosses2023-03-3113542265core:AfterOneYear2024-04-012025-03-3113542265core:WithinOneYear2024-04-012025-03-3113542265core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3113542265core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3113542265core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3113542265core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3113542265core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3113542265core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3113542265core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113542265core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113542265core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113542265core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3113542265core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3113542265core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3113542265core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3113542265core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3113542265core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3113542265core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3113542265core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3113542265core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3113542265core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113542265core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113542265core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113542265bus:Director12024-04-012025-03-3113542265bus:Director22024-04-012025-03-3113542265bus:Director32024-04-012025-03-3113542265bus:Director42024-04-012025-03-3113542265bus:Director52024-04-012025-03-3113542265bus:Director62024-04-012025-03-3113542265bus:Director72024-04-012025-03-31

NORTH ISLINGTON INTEGRATED CARE LIMITED

Registered Number
13542265
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

NORTH ISLINGTON INTEGRATED CARE LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

CHAKRABORTY, Anjan, Dr
HIRA, Jyotsna, Dr
IVENS, Kate
KALIMUTHU, Subhashini, Dr
KATEB, Heskel Jospeh, Dr
KOYA, Milan Mahendra, Dr
RACHI, Mohamed

Registered Address

Junction Medical Practice
18 Dartmouth Park Hill
London
NW5 1HL

Registered Number

13542265 (England and Wales)
NORTH ISLINGTON INTEGRATED CARE LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets31,257-
1,257-
Current assets
Debtors4816,954747,347
816,954747,347
Creditors amounts falling due within one year5(288,350)(387,945)
Net current assets (liabilities)528,604359,402
Total assets less current liabilities529,861359,402
Provisions for liabilities6(526,789)(356,330)
Net assets3,0723,072
Capital and reserves
Called up share capital77
Profit and loss account3,0653,065
Shareholders' funds3,0723,072
The financial statements were approved and authorised for issue by the Board of Directors on 18 November 2025, and are signed on its behalf by:
KATEB, Heskel Jospeh, Dr
Director
Registered Company No. 13542265
NORTH ISLINGTON INTEGRATED CARE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Plant and machinery15
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20252024
Average number of employees during the year3436
3.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
Additions1,4791,479
At 31 March 251,4791,479
Depreciation and impairment
Charge for year222222
At 31 March 25222222
Net book value
At 31 March 251,2571,257
At 31 March 24--
4.Debtors: amounts due within one year

2025

2024

££
Other debtors506,527723,752
Prepayments and accrued income310,42723,595
Total816,954747,347
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables77,919149,556
Other creditors30,61318,975
Accrued liabilities and deferred income179,818219,414
Total288,350387,945
6.Provisions for liabilities

2025

2024

££
Other provisions526,789356,330
Total526,789356,330